- Home
- FLC vs RGC Comparison
FLC vs RGC Comparison
Compare FLC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLC
- RGC
- Stock Information
- Founded
- FLC 2003
- RGC 2014
- Country
- FLC United States
- RGC Hong Kong
- Employees
- FLC N/A
- RGC N/A
- Industry
- FLC Trusts Except Educational Religious and Charitable
- RGC Medicinal Chemicals and Botanical Products
- Sector
- FLC Finance
- RGC Health Care
- Exchange
- FLC Nasdaq
- RGC Nasdaq
- Market Cap
- FLC 180.6M
- RGC 105.3M
- IPO Year
- FLC N/A
- RGC 2021
- Fundamental
- Price
- FLC $16.59
- RGC $4.86
- Analyst Decision
- FLC
- RGC
- Analyst Count
- FLC 0
- RGC 0
- Target Price
- FLC N/A
- RGC N/A
- AVG Volume (30 Days)
- FLC 37.8K
- RGC 8.8K
- Earning Date
- FLC 01-01-0001
- RGC 10-25-2024
- Dividend Yield
- FLC 6.64%
- RGC N/A
- EPS Growth
- FLC N/A
- RGC N/A
- EPS
- FLC N/A
- RGC N/A
- Revenue
- FLC N/A
- RGC N/A
- Revenue This Year
- FLC N/A
- RGC N/A
- Revenue Next Year
- FLC N/A
- RGC N/A
- P/E Ratio
- FLC N/A
- RGC N/A
- Revenue Growth
- FLC N/A
- RGC N/A
- 52 Week Low
- FLC $12.62
- RGC $3.03
- 52 Week High
- FLC $15.45
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- FLC 44.20
- RGC 44.96
- Support Level
- FLC $16.46
- RGC $4.75
- Resistance Level
- FLC $16.89
- RGC $5.21
- Average True Range (ATR)
- FLC 0.22
- RGC 0.30
- MACD
- FLC -0.01
- RGC 0.04
- Stochastic Oscillator
- FLC 36.00
- RGC 23.87
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.